Articles published by Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Tickers NTRB NTRBW

December 04, 2024

Tickers NTRB NTRBW

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

December 04, 2024

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Tickers NTRB NTRBW

November 27, 2024

Tickers NTRB NTRBW

Nutriband Inc. Announces Seven-for-Six Forward Stock Split

July 27, 2022

1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company

Tickers NTRB NTRBW

July 26, 2022

Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market

Tickers NTRB NTRBW

July 22, 2022

Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares

Tickers NTRB NTRBW

July 15, 2022

Topics Lawsuit

Tickers NTRB NTRBW

Nutriband Supports Update to CDC Opioid Prescribing Guidelines

June 03, 2022

Tickers NTRB NTRBW

Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)

May 27, 2022

Tickers NTRB NTRBW

Nutriband Inc. to Present at the Emerging Growth Conference on May 25

May 20, 2022

Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May

Tickers NTRB NTRBW

May 17, 2022

Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product

Tickers NTRB NTRBW

May 11, 2022

Topics Artificial Intelligence

Tickers NTRB NTRBW

Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M

April 29, 2022

Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice

Tickers NTRB

February 16, 2022

Topics Intellectual Property

Tickers NTRB NTRBW

Nutriband Inc. To Participate in The Benzinga All Access Event on February 4

February 04, 2022

Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office

Tickers NTRB NTRBW

January 28, 2022

Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology

Topics Intellectual Property

Tickers NTRB NTRBW

January 18, 2022

Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

Tickers NTRB NTRBW

January 10, 2022

Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Topics Intellectual Property

Tickers NTRB NTRBW

January 05, 2022

Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application

Topics Intellectual Property

Tickers NTRB NTRBW

December 31, 2021

Topics Intellectual Property

Tickers NTRB NTRBW

Nutriband Inc. Announces $1 Million Share Repurchase Authorization

December 29, 2021

Tickers NTRB NTRBW

Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services

December 21, 2021

Tickers NTRB NTRBW

Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary

December 13, 2021

Topics Intellectual Property

Tickers NTRB NTRBW

Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021

December 03, 2021

Topics Intellectual Property

Tickers NTRB NTRBW

Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl

November 16, 2021

Topics Intellectual Property

Tickers NTRB NTRBW

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

November 10, 2021

Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M

Topics Intellectual Property

Tickers NTRB NTRBW

October 22, 2021

Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch

Topics Intellectual Property

Tickers NTRB NTRBW

October 12, 2021

Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)

Topics Intellectual Property

Tickers NTRB NTRBW

October 04, 2021